Judge Pushes Resolution In Vanda, FDA Gastro Drug Fight
By Katie Buehler ( January 11, 2023, 5:32 PM EST) -- A D.C. federal judge on Wednesday said Vanda Pharmaceuticals Inc. and the U.S. Food and Drug Administration seemed to be arguing past each other in a case challenging the FDA's rejection of the company's anti-nausea drug for patients with a chronic gastric condition and suggested the dispute could be resolved if Vanda submitted a new, revised application....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.